Medesis Pharma (STU:76D) Other Long-Term Liabilities : €1.17 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Medesis Pharma Other Long-Term Liabilities?

Medesis Pharma's other long-term liabilities for the quarter that ended in Jun. 2024 was €1.17 Mil.

Medesis Pharma's quarterly other long-term liabilities declined from Jun. 2023 (€1.11 Mil) to Dec. 2023 (€1.10 Mil) but then increased from Dec. 2023 (€1.10 Mil) to Jun. 2024 (€1.17 Mil).

Medesis Pharma's annual other long-term liabilities increased from Dec. 2021 (€0.96 Mil) to Dec. 2022 (€1.01 Mil) and increased from Dec. 2022 (€1.01 Mil) to Dec. 2023 (€1.10 Mil).

Medesis Pharma Other Long-Term Liabilities Historical Data

The historical data trend for Medesis Pharma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma Other Long-Term Liabilities Chart

Medesis Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

0.83

0.94

0.96

1.01

1.10

Medesis Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial						0.94	1.01	1.11	1.10	1.17

Medesis Pharma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Medesis Pharma Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medesis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (STU:76D) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670

Website

https://www.medesispharma.com

Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines